Number of Employees
6200
Ticker
ENDP (SDAQ)
Revenue
$1,415.0
CDMO
Par Pharmaceutical develops, manufactures and markets safe, innovative and cost-effective generic pharmaceutical products that help improve patient quality of life. Par offers differentiated, specialty dosage and sterile injectable drug products and is advancing a R&D pipeline of potential new products. Par Pharmaceutical is an operating company of Endo International plc, a global specialty pharmaceutical company focused on improving patients’ lives while creating shareholder value.
Nice Insight/That’s Nice
89 Fifth AvenueFifth FloorNew YorkNY 10003-3020
New York – San Diego – ChicagoLondon – Frankfurt – Shanghai
Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.